| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 04/15/2004 | CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/14/2004 | EP1407053A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1406999A1 Recovery of bioleaching microbes |
| 04/08/2004 | WO2004029211A2 Frozen spermatozoa compositions and uses thereof |
| 04/08/2004 | WO2004029196A2 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith |
| 04/08/2004 | WO2003106614A3 Composition containing at least one silicone-polyamide structured oil and a gelling agent, and methods of the use thereof |
| 04/08/2004 | WO2003076585A3 Controlled modulation of amino acid side chain length of peptide antigens |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067507 A method of predicting the liver toxicity In Vivo or In Vitro comprising obtaining a biological sample from an individual, cell culture or explant treated with the agent, measurinf the expression of predictive genes in the sample |
| 04/08/2004 | US20040067492 Reverse transcription on microarrays |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/01/2004 | WO2004027027A2 Method of inhibiting choroidal neovascularization |
| 04/01/2004 | WO2004027024A2 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis |
| 04/01/2004 | WO2004027021A2 Device and methods for isolating target cells |
| 04/01/2004 | WO2004016766A3 Real time measurement of cellular responses |
| 04/01/2004 | WO2003106652A3 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/01/2004 | WO2003106630A3 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 04/01/2004 | WO2003089609A3 Short fragment homologous replacement to provide bse resistant cattle |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003040286A3 Cdw92 molecule induced immunomodulation |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/25/2004 | WO2004024886A2 Microarray synthesis and assembly of gene-length polynucleotides |
| 03/25/2004 | WO2003040315A3 Method of encoding characteristics of a biological sample |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058340 Diagnosis and prognosis of breast cancer patients |
| 03/25/2004 | US20040057964 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | CA2498746A1 Microarray synthesis and assembly of gene-length polynucleotides |
| 03/18/2004 | WO2004022721A2 Quantification of gene expression |
| 03/18/2004 | WO2004022714A2 Organic species that facilitate charge transfer to or from nanostructures |
| 03/18/2004 | WO2004003168A3 Clustering biological data using mutual information |
| 03/18/2004 | WO2003078583A3 Optimization of crossover points for directed evolution |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003014308A3 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 03/18/2004 | US20040054162 Comprises nucleoside/nucleotide/nucleic acid comprises substituted pyrimidine/purine derivatives; high speed; polymerases; blot analysis |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040053873 Electroporation methods for introducing bioactive agents into cells |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053319 Liquefying complex biological constructs, extracting RNA and monitoring gene expression |
| 03/18/2004 | US20040053277 Using microarrays to identify gene expression patterns associated with glioblastoma multiforme (GM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO) or oligodendroglioma (OL); prognosing metatstatic tumors |
| 03/18/2004 | US20040053243 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 03/18/2004 | CA2497451A1 Organic species that facilitate charge transfer to or from nanostructures |
| 03/17/2004 | EP0991766B1 Regulation of quinolate phosphoribosyl transferase expression |
| 03/11/2004 | WO2004020602A2 Terminal phosphate blocked nucleoside polyphosphates |
| 03/11/2004 | WO2004020592A2 Retroductal salivary gland genetic vaccination |
| 03/11/2004 | WO2004020588A2 Transferrin fusion protein libraries |
| 03/11/2004 | WO2003035826A3 Genetic screening methods |
| 03/10/2004 | EP1395676A1 Viral drug susceptibility testing |
| 03/04/2004 | WO2004018648A2 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018626A2 Abasic site endonuclease assay |
| 03/04/2004 | WO2003078603A3 Strong gene sets for glioma classification |
| 03/04/2004 | WO2003031565A3 Integrated system and method for analysis of genomic sequence data |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040045046 Transgenic mammals expressing polyglutamine |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040042971 Spray freeze dry of compositions for pulmonary administration |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | CA2494993A1 Abasic site endonuclease assay |
| 03/03/2004 | EP1392872A2 Non-alloying core shell nanoparticles |
| 02/26/2004 | WO2004016766A2 Real time measurement of cellular responses |
| 02/26/2004 | WO2004016765A2 Method for search based character optimization |
| 02/26/2004 | WO2004016757A2 Methods, compositions and kits for producing nucleic and acid sequences |
| 02/26/2004 | WO2004016755A2 Amplification of target nucleotide sequence without polymerase chain reaction |
| 02/26/2004 | WO2004016751A2 Methods of treating neurodegenerative diseases |
| 02/26/2004 | WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 02/26/2004 | WO2003089590A3 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH |
| 02/26/2004 | WO2003066812A3 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing |
| 02/26/2004 | WO2003064615A3 Amplifying repetitive nucleic acid sequences |
| 02/26/2004 | WO2003046146A3 Compositions and methods of selective nucleic acid isolation |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | US20040038308 Hybrid antibodies |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038255 Silver-gold shelled composite oligonucleotide conjugate for detecting target nucleic acids, peptides and proteins; colorimetric based DNA detection |
| 02/26/2004 | US20040037874 Delivery of nucleic acid-like compounds |
| 02/26/2004 | CA2507486A1 .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom |
| 02/26/2004 | CA2495411A1 Real time measurement of cellular responses |
| 02/19/2004 | WO2004015081A2 Methods for treating circadian rhythm phase disturbances |
| 02/19/2004 | WO2004015080A2 Nucleic acid detection methods using universal priming |
| 02/19/2004 | WO2004015079A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2004015076A2 Novel proteins and nucleic acids encoding same |
| 02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004001016A3 Methods for detection of genetic alterations associated with cancer |
| 02/19/2004 | WO2003095620A3 Oocyte recording chamber |
| 02/19/2004 | WO2003042364A3 Identifying and controlling the growth of estrogen-responsive cells |
| 02/19/2004 | WO2002097072A8 Influenza vaccine composition |
| 02/19/2004 | WO2002083852A3 Microfermentor device and cell based screening method |
| 02/19/2004 | US20040033602 Using small interfering RNA (siRNA) sequences and polypeptides containing enzymatic domains to control gene expression in cell systems; antisense agents |
| 02/19/2004 | US20040033549 Quorum sensing signaling in bacteria |
| 02/19/2004 | US20040033485 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data |
| 02/19/2004 | CA2495563A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |